Recipe - Compounding Worksheet
Unauthorized distribution, copying or disclosure prohibited.
These recipes are intended for use by the pharmacy manufacturing departments only.
Sildenafil Oral Suspension    2.5 mg/mL
Lot No Expiry(mm/yyyy) Ingredients Master Formula
    sildenafil  20 mg  TAB   
    Ora-Plus® / Ora-Sweet®  1:1  SYRUP  qs to 
Recipe Total Quantity:
Final Quantity Desired: mL

Directions: 1. In a mortar, crush tablets and triturate to a FINE powder.
2. Mix Ora-Plus® and Ora-Sweet® together (1:1) to make vehicle.
3. Gradually levigate powder with vehicle until a liquid is formed.
4. Pour into a graduated cylinder.
5. Rinse mortar and qs to final volume with vehicle.
6. Transfer to final container and label.

Notes NOTE:
Only Revatio®, Apo-Sildenafil R tablets and Alberta Health approved interchangeable generic products covered by Province Wide Services for the treatment of primary pulmonary hypertension and are formulary. Viagra® tablets are not covered by Province Wide Services and are non-formulary.
Refer to Sildenafil tablets on AHS Provincial Formulary.

May substitute Ora Plus® / Ora Sweet® (1:1) with any of the following vehicles:
- Ora-Blend®
- Methylcellulose 1% (preserved with parabens)/ Simple Syrup (1:1)

Ensure tablets are in a FINE powder form prior to levigating with liquid mixture to prevent flecks of coating from the tablets appearing in the final suspension.

Alternatively, tablets can be soaked in enough Ora-Plus® and Ora-Sweet® (1:1) to cover tablets and allowed to sit for 40 minutes until tablets soften. Triturate mixture to form a paste and add Ora-Plus® and Ora-Sweet® (1:1) to qs to final required volume.

Packaging: 100 mL Amber Plastic Bottle

Auxiliary Labels: Can be stored at room temperature or refrigerated
  Shake Well

Storage/Expiry:Refrigerator or Room Temperature: 91 days

Last Date Revised: 25-Jan-21

References:Nahata MC. Morosco RS. Brady MT. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children. Am J Health-Syst Pharm 2006; 63(3): 254-257.

Formulations: Sildenafil citrate 2.5-mg/mL oral liquid. International Journal of Pharmaceutical Compounding. 2006; 10(4):306.

Formulations: Sildenafil citrate 2.5-mg/mL in Ora-Plus:Ora-Sweet. International Journal of Pharmaceutical Compounding. 2019;23(3):236.

Nahata MC. Extended stability of morphine and sildenafil for oral use in infants and young children. International Journal of Pharmaceutical Compounding 2016;20(3):247-249.

Completed Compound Check
Lot NoDate Prepared Expiry DateTechnicianPharmacist
   6-Dec-2021         


This content is provided for general information purposes only. It is not intended to replace consultations with a health care professional or to provide medical advice, diagnosis or treatment. Always seek the advice of a physician or other qualified health care provider with any medical or health questions. Alberta Health Services accepts no responsibility for any modification or redistribution of this document and is not liable for any actions taken by individuals based on the information provided, or for any inaccuracies, errors, or omissions in the information in this document. These recipes are to be used as a reference and are not intended to be master formulation records. Not all recipes may be compliant with NAPRA or other standards.